Persistent bisphosphonate use and the risk of osteoporotic fractures in clinical practice: a database analysis study
van den Boogaard, C. H. A., Breekveldt‐Postma, N. S., Borggreve, S. E., Goettsch, W. G., Herings, R. M. C.
Published in Current medical research and opinion (01.09.2006)
Published in Current medical research and opinion (01.09.2006)
Get full text
Journal Article
Persistence with inhaled corticosteroid therapy in daily practice
Breekveldt-Postma, N.S, Gerrits, C.M.J.M, Lammers, J.W.J, Raaijmakers, J.A.M, Herings, R.M.C
Published in Respiratory medicine (01.08.2004)
Published in Respiratory medicine (01.08.2004)
Get full text
Journal Article
Utilisation pattern of fentanyl transdermal system in The Netherlands
Breekveldt-Postma, N. S., Penning-van Beest, F. J. A., Herings, R. M. C.
Published in Pharmacoepidemiology and drug safety (01.02.2005)
Published in Pharmacoepidemiology and drug safety (01.02.2005)
Get full text
Journal Article
Diffusion of new medicines into hospital practice
Zwart-van Rijkom, J E F, Breekveldt-Postma, N S, Leufkens, H G M, Egberts, A C G
Published in European journal of clinical pharmacology (01.09.2003)
Published in European journal of clinical pharmacology (01.09.2003)
Get full text
Journal Article
Treatment with liposome-bound recombinant human tumor necrosis factor-alpha suppresses parasitemia and protects against Plasmodium berghei k173-induced experimental cerebral malaria in mice
Postma, N S, Crommelin, D J, Eling, W M, Zuidema, J
Published in The Journal of pharmacology and experimental therapeutics (01.01.1999)
Get full text
Published in The Journal of pharmacology and experimental therapeutics (01.01.1999)
Journal Article
Treatment with recombinant human tumour necrosis factor-alpha reduces parasitaemia and prevents Plasmodium berghei K173-induced experimental cerebral malaria in mice
Postma, N S, Hermsen, C C, Crommelin, D J, Zuidema, J, Eling, W M
Published in Parasitology (01.01.1999)
Published in Parasitology (01.01.1999)
Get more information
Journal Article
Plasmodium vinckei:Optimization of Desferrioxamine B Delivery in the Treatment of Murine Malaria
Postma, N.S., Hermsen, C.C., Zuidema, J., Eling, W.M.C.
Published in Experimental parasitology (01.07.1998)
Published in Experimental parasitology (01.07.1998)
Get full text
Journal Article
Maintenance of the synthesis of large proteoglycans in anatomically intact murine articular cartilage by steroids and insulin-like growth factor I
van der Kraan, P M, Vitters, E L, Postma, N S, Verbunt, J, van den Berg, W B
Published in Annals of the rheumatic diseases (01.10.1993)
Published in Annals of the rheumatic diseases (01.10.1993)
Get full text
Journal Article
Thiolated recombinant human tumor necrosis factor-alpha protects against Plasmodium berghei K173-induced experimental cerebral malaria in mice
POSTMA, N. S, HERMSEN, R. C, CROMMELIN, D. J. A, ELING, W. M. C, ZUIDEMA, J
Published in Antimicrobial agents and chemotherapy (01.05.1999)
Published in Antimicrobial agents and chemotherapy (01.05.1999)
Get full text
Journal Article
Oxidative stress in malaria; implications for prevention and therapy
Postma, N S, Mommers, E C, Eling, W M, Zuidema, J
Published in Pharmacy world and science (01.08.1996)
Published in Pharmacy world and science (01.08.1996)
Get more information
Journal Article
Treatment with Liposome-Bound Recombinant Human Tumor Necrosis Factor-α Suppresses Parasitemia and Protects againstPlasmodium berghei k173-Induced Experimental Cerebral Malaria in Mice
N. S. Postma, D. J. A. Crommelin, W. M. C. Eling, J. Zuidema
Published in The Journal of pharmacology and experimental therapeutics (01.01.1999)
Get full text
Published in The Journal of pharmacology and experimental therapeutics (01.01.1999)
Journal Article
Persistence with antihypertensives related to formulation: the case of nifedipine
Breekveldt-Postma, Nancy S, Herings, Ron M C
Published in The Annals of pharmacotherapy (01.02.2005)
Published in The Annals of pharmacotherapy (01.02.2005)
Get more information
Journal Article
AO3 PERSISTENT USE OF ANTIHYPERTENSIVE DRUGS LEADS TO A 1.5-2 TIMES INCREASED CHANCE OF BLOOD PRESSURE GOAL ATTAINMENT IN STAGE 2 ANTIHYPERTENSIVE PATIENTS
Breekveldt-Postma, NS, Siiskonen, SJ, Penning-van Beest, FJA, Erkens, JA, Vincze, G, Falvey, H, Herings, RMC
Published in Value in health (2007)
Published in Value in health (2007)
Get full text
Journal Article